

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.64706354 |
| 2 | response to pheromone (GO:0019236) | 3.94222338 |
| 3 | protein complex biogenesis (GO:0070271) | 3.91391452 |
| 4 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.81434768 |
| 5 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.80841566 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.80841566 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 3.80841566 |
| 8 | * mismatch repair (GO:0006298) | 3.80221268 |
| 9 | rRNA modification (GO:0000154) | 3.75278130 |
| 10 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.75058837 |
| 11 | protein deneddylation (GO:0000338) | 3.58427820 |
| 12 | mannosylation (GO:0097502) | 3.58047262 |
| 13 | aggressive behavior (GO:0002118) | 3.57595458 |
| 14 | cullin deneddylation (GO:0010388) | 3.54152801 |
| 15 | metallo-sulfur cluster assembly (GO:0031163) | 3.53103534 |
| 16 | iron-sulfur cluster assembly (GO:0016226) | 3.53103534 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 3.51846332 |
| 18 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.44714524 |
| 19 | rRNA methylation (GO:0031167) | 3.42106482 |
| 20 | platelet dense granule organization (GO:0060155) | 3.41508399 |
| 21 | cytidine metabolic process (GO:0046087) | 3.38631157 |
| 22 | cytidine catabolic process (GO:0006216) | 3.38631157 |
| 23 | cytidine deamination (GO:0009972) | 3.38631157 |
| 24 | proteasome assembly (GO:0043248) | 3.36255067 |
| 25 | branched-chain amino acid catabolic process (GO:0009083) | 3.34771009 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.31708533 |
| 27 | seminiferous tubule development (GO:0072520) | 3.31001187 |
| 28 | GPI anchor biosynthetic process (GO:0006506) | 3.30249466 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.28246836 |
| 30 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.27749560 |
| 31 | protein-cofactor linkage (GO:0018065) | 3.25403492 |
| 32 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.23887511 |
| 33 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.23887511 |
| 34 | GPI anchor metabolic process (GO:0006505) | 3.22647498 |
| 35 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.20336768 |
| 36 | protein neddylation (GO:0045116) | 3.19860010 |
| 37 | cytochrome complex assembly (GO:0017004) | 3.18082442 |
| 38 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.12105215 |
| 39 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.11237044 |
| 40 | negative regulation of telomere maintenance (GO:0032205) | 3.10900254 |
| 41 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.10440049 |
| 42 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.10296911 |
| 43 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.10296911 |
| 44 | mitochondrial RNA metabolic process (GO:0000959) | 3.06057553 |
| 45 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.05977018 |
| 46 | maturation of 5.8S rRNA (GO:0000460) | 3.05973926 |
| 47 | DNA double-strand break processing (GO:0000729) | 3.05368439 |
| 48 | C-terminal protein lipidation (GO:0006501) | 3.04295725 |
| 49 | adenosine metabolic process (GO:0046085) | 2.98378574 |
| 50 | deoxyribonucleotide catabolic process (GO:0009264) | 2.98298240 |
| 51 | ubiquinone biosynthetic process (GO:0006744) | 2.97614370 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.94876044 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.94629926 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.93294974 |
| 55 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92396423 |
| 56 | positive regulation of prostaglandin secretion (GO:0032308) | 2.91977121 |
| 57 | oxidative phosphorylation (GO:0006119) | 2.91414743 |
| 58 | actin nucleation (GO:0045010) | 2.91051633 |
| 59 | ubiquinone metabolic process (GO:0006743) | 2.89322185 |
| 60 | base-excision repair, AP site formation (GO:0006285) | 2.88957486 |
| 61 | branched-chain amino acid metabolic process (GO:0009081) | 2.84508418 |
| 62 | deoxyribose phosphate catabolic process (GO:0046386) | 2.84136645 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.83903613 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.83903613 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.83903613 |
| 66 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.83190696 |
| 67 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.83190696 |
| 68 | C-terminal protein amino acid modification (GO:0018410) | 2.82939449 |
| 69 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.81017220 |
| 70 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.80935287 |
| 71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.78959859 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 2.78959859 |
| 73 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78114069 |
| 74 | S-adenosylmethionine metabolic process (GO:0046500) | 2.78090790 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 2.78065342 |
| 76 | negative regulation of ligase activity (GO:0051352) | 2.76907893 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.76907893 |
| 78 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75962281 |
| 79 | DNA integration (GO:0015074) | 2.73737156 |
| 80 | aldehyde catabolic process (GO:0046185) | 2.73634292 |
| 81 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72771627 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.69022637 |
| 83 | peptidyl-histidine modification (GO:0018202) | 2.68614901 |
| 84 | pseudouridine synthesis (GO:0001522) | 2.66787043 |
| 85 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.65735918 |
| 86 | GMP metabolic process (GO:0046037) | 2.65732576 |
| 87 | glycolipid biosynthetic process (GO:0009247) | 2.65695725 |
| 88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.65218619 |
| 89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.65218619 |
| 90 | DNA damage response, detection of DNA damage (GO:0042769) | 2.64808360 |
| 91 | succinate metabolic process (GO:0006105) | 2.64738651 |
| 92 | histone H2A acetylation (GO:0043968) | 2.63733335 |
| 93 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.63370044 |
| 94 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.61230265 |
| 95 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.60895925 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 2.60884881 |
| 97 | tRNA processing (GO:0008033) | 2.60243093 |
| 98 | respiratory electron transport chain (GO:0022904) | 2.59786253 |
| 99 | amino acid salvage (GO:0043102) | 2.58876283 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 2.58876283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.46727715 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.01291863 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.83898050 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.46309665 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.42719726 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.36214132 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.35120663 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.24779187 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.21856352 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.80549142 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.73395709 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72961562 |
| 13 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.55245403 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39537615 |
| 15 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.29835811 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.27194520 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.13790912 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13166614 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.09749899 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.08980441 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96467280 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.95472522 |
| 23 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.80746147 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78188059 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74005965 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68721126 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68303298 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67410642 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66398563 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.66119042 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.65229305 |
| 32 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63171697 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61487706 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61416090 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60366144 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.59046306 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58531736 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57649110 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57089165 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55810342 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53513485 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52435411 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50018851 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44488588 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43069277 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.42080857 |
| 47 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41105557 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38360745 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36211559 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36181838 |
| 51 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34901455 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27780572 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24832169 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24660429 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23786236 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.23621850 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23544068 |
| 58 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23152308 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20183934 |
| 60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16983846 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16582014 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15783181 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15501993 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13579548 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12526897 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11790834 |
| 67 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10379487 |
| 68 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10313220 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09411292 |
| 70 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09253091 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08925676 |
| 72 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08494285 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.08187786 |
| 74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08180736 |
| 75 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06587509 |
| 76 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06587509 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06383036 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06056886 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06056886 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04385645 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03362040 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02422093 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.02219357 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02187507 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97049560 |
| 86 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95278707 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95278707 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95113181 |
| 89 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95045787 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94541861 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94369814 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93660702 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93236295 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92615657 |
| 95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92186652 |
| 96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.89686214 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88902513 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86179279 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83625847 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.83145121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 3.44772780 |
| 2 | MP0004147_increased_porphyrin_level | 3.12118610 |
| 3 | MP0008877_abnormal_DNA_methylation | 3.04071801 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 2.89357937 |
| 5 | MP0008058_abnormal_DNA_repair | 2.87619506 |
| 6 | MP0001529_abnormal_vocalization | 2.82005829 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.25772685 |
| 8 | MP0002736_abnormal_nociception_after | 2.14295335 |
| 9 | MP0003880_abnormal_central_pattern | 2.14130712 |
| 10 | MP0009697_abnormal_copulation | 2.13800034 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06712319 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.06565113 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.01427499 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.00236274 |
| 15 | MP0006292_abnormal_olfactory_placode | 1.94584220 |
| 16 | MP0003718_maternal_effect | 1.92836153 |
| 17 | MP0003786_premature_aging | 1.88974857 |
| 18 | MP0008789_abnormal_olfactory_epithelium | 1.88802167 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 1.88521316 |
| 20 | MP0001984_abnormal_olfaction | 1.80943332 |
| 21 | MP0005253_abnormal_eye_physiology | 1.72969257 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.72473966 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.70744694 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.65238272 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.64563423 |
| 26 | MP0001764_abnormal_homeostasis | 1.63677984 |
| 27 | MP0003195_calcinosis | 1.62348614 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.62135175 |
| 29 | MP0005499_abnormal_olfactory_system | 1.59644895 |
| 30 | MP0005394_taste/olfaction_phenotype | 1.59644895 |
| 31 | MP0003186_abnormal_redox_activity | 1.57227783 |
| 32 | MP0008872_abnormal_physiological_respon | 1.55530763 |
| 33 | MP0008995_early_reproductive_senescence | 1.55101842 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.51335696 |
| 35 | MP0001905_abnormal_dopamine_level | 1.49558130 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.46879420 |
| 37 | MP0003787_abnormal_imprinting | 1.45332497 |
| 38 | MP0005410_abnormal_fertilization | 1.43008464 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.42906675 |
| 40 | MP0003011_delayed_dark_adaptation | 1.41607237 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.40950778 |
| 42 | MP0009046_muscle_twitch | 1.39578119 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.24311277 |
| 44 | MP0002132_abnormal_respiratory_system | 1.21819011 |
| 45 | MP0003122_maternal_imprinting | 1.21008511 |
| 46 | MP0000358_abnormal_cell_content/ | 1.16884904 |
| 47 | MP0005671_abnormal_response_to | 1.16182830 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.15571558 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.10451502 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.07689490 |
| 51 | MP0000516_abnormal_urinary_system | 1.07689490 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.04999133 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.03834356 |
| 54 | MP0004142_abnormal_muscle_tone | 1.03813472 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.03618408 |
| 56 | MP0009764_decreased_sensitivity_to | 1.03305133 |
| 57 | MP0001929_abnormal_gametogenesis | 1.03031848 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.02159322 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 0.99760702 |
| 60 | MP0002272_abnormal_nervous_system | 0.97312084 |
| 61 | MP0005423_abnormal_somatic_nervous | 0.97147705 |
| 62 | MP0005332_abnormal_amino_acid | 0.95271844 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.94500444 |
| 64 | MP0009745_abnormal_behavioral_response | 0.92432475 |
| 65 | MP0009785_altered_susceptibility_to | 0.91315843 |
| 66 | MP0000689_abnormal_spleen_morphology | 0.88046035 |
| 67 | MP0001800_abnormal_humoral_immune | 0.87704650 |
| 68 | MP0004043_abnormal_pH_regulation | 0.86880248 |
| 69 | MP0001970_abnormal_pain_threshold | 0.86727818 |
| 70 | MP0002557_abnormal_social/conspecific_i | 0.86270357 |
| 71 | MP0003698_abnormal_male_reproductive | 0.86258283 |
| 72 | MP0002822_catalepsy | 0.85850956 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.83694756 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.82719050 |
| 75 | MP0008932_abnormal_embryonic_tissue | 0.81989660 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.81647084 |
| 77 | MP0004133_heterotaxia | 0.81115362 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.81009243 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.79301553 |
| 80 | MP0005266_abnormal_metabolism | 0.79231043 |
| 81 | MP0005389_reproductive_system_phenotype | 0.77797139 |
| 82 | MP0002723_abnormal_immune_serum | 0.76470580 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.76004037 |
| 84 | MP0003121_genomic_imprinting | 0.75941803 |
| 85 | MP0006054_spinal_hemorrhage | 0.75820983 |
| 86 | MP0002653_abnormal_ependyma_morphology | 0.74229247 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.73830092 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.72730158 |
| 89 | MP0001119_abnormal_female_reproductive | 0.70898069 |
| 90 | MP0000685_abnormal_immune_system | 0.70745575 |
| 91 | MP0005395_other_phenotype | 0.70732602 |
| 92 | MP0001661_extended_life_span | 0.70337564 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.69606166 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.67615372 |
| 95 | MP0003724_increased_susceptibility_to | 0.67587092 |
| 96 | MP0000653_abnormal_sex_gland | 0.67092906 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.66484553 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.66264631 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.65946700 |
| 100 | MP0003252_abnormal_bile_duct | 0.64464226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.35784677 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.30533767 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.28555878 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.21890783 |
| 5 | Acute encephalopathy (HP:0006846) | 3.96864098 |
| 6 | Hepatic necrosis (HP:0002605) | 3.95923933 |
| 7 | Increased CSF lactate (HP:0002490) | 3.89054778 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.65362391 |
| 9 | Decreased central vision (HP:0007663) | 3.34489838 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 3.22951802 |
| 11 | Cerebral edema (HP:0002181) | 3.21303778 |
| 12 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.03620162 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.00645936 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 2.97865080 |
| 15 | Increased serum lactate (HP:0002151) | 2.93110193 |
| 16 | Lactic acidosis (HP:0003128) | 2.92879665 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 2.91448167 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 2.88165383 |
| 19 | Pancreatic fibrosis (HP:0100732) | 2.86621239 |
| 20 | Amyotrophic lateral sclerosis (HP:0007354) | 2.81305794 |
| 21 | Pancreatic cysts (HP:0001737) | 2.81104081 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.77727366 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.77727366 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.77727366 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.77727366 |
| 26 | True hermaphroditism (HP:0010459) | 2.72672272 |
| 27 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.72149093 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.72149093 |
| 29 | Degeneration of anterior horn cells (HP:0002398) | 2.70415738 |
| 30 | Abnormality of the anterior horn cell (HP:0006802) | 2.70415738 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.67033709 |
| 32 | Microvesicular hepatic steatosis (HP:0001414) | 2.58579617 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 2.55107439 |
| 34 | Methylmalonic acidemia (HP:0002912) | 2.52424876 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 2.51901971 |
| 36 | Increased muscle lipid content (HP:0009058) | 2.51222285 |
| 37 | Medial flaring of the eyebrow (HP:0010747) | 2.49182617 |
| 38 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.45268424 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.41894548 |
| 40 | Exercise intolerance (HP:0003546) | 2.39069706 |
| 41 | Nephronophthisis (HP:0000090) | 2.37949655 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36914395 |
| 43 | Respiratory failure (HP:0002878) | 2.33034889 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 2.32651560 |
| 45 | Optic disc pallor (HP:0000543) | 2.31876921 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.31477484 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.31477484 |
| 48 | Hyperalaninemia (HP:0003348) | 2.31477484 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 2.29421597 |
| 50 | Lethargy (HP:0001254) | 2.28548655 |
| 51 | Colon cancer (HP:0003003) | 2.27421495 |
| 52 | Aplastic anemia (HP:0001915) | 2.27223190 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.26519155 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.26519155 |
| 55 | Short tibia (HP:0005736) | 2.25264109 |
| 56 | Increased corneal curvature (HP:0100692) | 2.24904748 |
| 57 | Keratoconus (HP:0000563) | 2.24904748 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.22855826 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.19072165 |
| 60 | CNS demyelination (HP:0007305) | 2.17232448 |
| 61 | Abnormality of glycolysis (HP:0004366) | 2.16150375 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16006603 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16004377 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.16004377 |
| 65 | Abnormality of macular pigmentation (HP:0008002) | 2.15563626 |
| 66 | Emotional lability (HP:0000712) | 2.14323596 |
| 67 | Congenital stationary night blindness (HP:0007642) | 2.12762085 |
| 68 | Retinal dysplasia (HP:0007973) | 2.11586528 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.06966631 |
| 70 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04966995 |
| 71 | Type II lissencephaly (HP:0007260) | 2.04051113 |
| 72 | Renal cortical cysts (HP:0000803) | 2.03934574 |
| 73 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03704771 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03392284 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03003404 |
| 76 | Bile duct proliferation (HP:0001408) | 2.01038859 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 2.01038859 |
| 78 | Progressive inability to walk (HP:0002505) | 2.00176604 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.99618599 |
| 80 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98665495 |
| 81 | Ependymoma (HP:0002888) | 1.98420208 |
| 82 | IgG deficiency (HP:0004315) | 1.98366916 |
| 83 | Gonadotropin excess (HP:0000837) | 1.98200006 |
| 84 | Congenital primary aphakia (HP:0007707) | 1.97364230 |
| 85 | Hypothermia (HP:0002045) | 1.96089563 |
| 86 | Inability to walk (HP:0002540) | 1.93631783 |
| 87 | Gait imbalance (HP:0002141) | 1.93629987 |
| 88 | Ketosis (HP:0001946) | 1.93579367 |
| 89 | Hyperglycinuria (HP:0003108) | 1.91327464 |
| 90 | Abnormality of B cell number (HP:0010975) | 1.91243259 |
| 91 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.89843486 |
| 92 | Ketoacidosis (HP:0001993) | 1.84544768 |
| 93 | Abnormality of the renal medulla (HP:0100957) | 1.81332418 |
| 94 | Postaxial foot polydactyly (HP:0001830) | 1.81166966 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 1.80391439 |
| 96 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78484325 |
| 97 | Chronic hepatic failure (HP:0100626) | 1.76820635 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 1.75035522 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75035522 |
| 100 | Hyperglycinemia (HP:0002154) | 1.73811042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 4.26523313 |
| 2 | VRK2 | 3.65231461 |
| 3 | TAOK3 | 3.47202992 |
| 4 | EIF2AK3 | 2.87404983 |
| 5 | NUAK1 | 2.87066083 |
| 6 | BCKDK | 2.81066631 |
| 7 | SRPK1 | 2.20783677 |
| 8 | CSNK1G3 | 2.13602716 |
| 9 | EIF2AK1 | 1.99792188 |
| 10 | MST4 | 1.89688139 |
| 11 | KDR | 1.89602437 |
| 12 | BCR | 1.83196748 |
| 13 | CSNK1A1L | 1.80274029 |
| 14 | TRIM28 | 1.78224382 |
| 15 | BUB1 | 1.77632423 |
| 16 | MAP2K7 | 1.72819895 |
| 17 | VRK1 | 1.72005485 |
| 18 | CSNK1G2 | 1.70300237 |
| 19 | MAP3K4 | 1.70197476 |
| 20 | CSNK1G1 | 1.62244730 |
| 21 | MAPK13 | 1.50050011 |
| 22 | DAPK1 | 1.46507236 |
| 23 | FRK | 1.42040957 |
| 24 | NME1 | 1.41943009 |
| 25 | ADRBK2 | 1.37419084 |
| 26 | TXK | 1.29513030 |
| 27 | PIM2 | 1.29047964 |
| 28 | PLK2 | 1.28136228 |
| 29 | PINK1 | 1.26433764 |
| 30 | CCNB1 | 1.24307852 |
| 31 | WNK3 | 1.18820345 |
| 32 | KIT | 1.18129367 |
| 33 | GRK1 | 1.17976808 |
| 34 | PLK4 | 1.15780144 |
| 35 | TAF1 | 1.14806341 |
| 36 | DYRK2 | 1.14330760 |
| 37 | MAP4K1 | 1.13854637 |
| 38 | ERBB3 | 1.08486926 |
| 39 | MAPKAPK3 | 1.07907946 |
| 40 | PDK2 | 1.06911740 |
| 41 | ZAK | 1.04294195 |
| 42 | NEK1 | 1.04057609 |
| 43 | MKNK1 | 1.04054381 |
| 44 | IKBKB | 1.01288203 |
| 45 | FLT3 | 1.00899652 |
| 46 | GRK5 | 1.00828353 |
| 47 | TESK2 | 1.00312102 |
| 48 | LIMK1 | 1.00249352 |
| 49 | MAP3K12 | 0.99657716 |
| 50 | CDK19 | 0.94310590 |
| 51 | EIF2AK2 | 0.86913987 |
| 52 | SYK | 0.85161675 |
| 53 | RPS6KA4 | 0.82648264 |
| 54 | PLK3 | 0.80759958 |
| 55 | STK16 | 0.77434175 |
| 56 | MAPKAPK5 | 0.76245424 |
| 57 | TEC | 0.72724444 |
| 58 | CDC7 | 0.72692232 |
| 59 | PHKG1 | 0.70888066 |
| 60 | PHKG2 | 0.70888066 |
| 61 | INSRR | 0.69610121 |
| 62 | MUSK | 0.69311798 |
| 63 | ATR | 0.67913548 |
| 64 | CLK1 | 0.67605442 |
| 65 | TIE1 | 0.66852526 |
| 66 | MAP3K5 | 0.66549377 |
| 67 | TBK1 | 0.66046170 |
| 68 | RPS6KA5 | 0.65866453 |
| 69 | BMPR1B | 0.64578605 |
| 70 | PRKCE | 0.61232086 |
| 71 | PAK3 | 0.59699547 |
| 72 | CASK | 0.59463461 |
| 73 | ITK | 0.55263210 |
| 74 | TESK1 | 0.54930622 |
| 75 | OXSR1 | 0.54233961 |
| 76 | GRK6 | 0.53246979 |
| 77 | IKBKE | 0.52569508 |
| 78 | PRKCQ | 0.51051226 |
| 79 | BMPR2 | 0.49097670 |
| 80 | PBK | 0.47698331 |
| 81 | CSNK1A1 | 0.47056198 |
| 82 | TSSK6 | 0.46749095 |
| 83 | PIK3CA | 0.46544262 |
| 84 | CSF1R | 0.45283726 |
| 85 | NME2 | 0.45129169 |
| 86 | LYN | 0.44856881 |
| 87 | PLK1 | 0.44520778 |
| 88 | CDK8 | 0.43875680 |
| 89 | MINK1 | 0.43425047 |
| 90 | CSNK2A1 | 0.39516038 |
| 91 | CSNK2A2 | 0.36824212 |
| 92 | CAMK2A | 0.36437106 |
| 93 | TLK1 | 0.36237643 |
| 94 | PRKCG | 0.34769083 |
| 95 | CAMK2D | 0.33188029 |
| 96 | LCK | 0.33149159 |
| 97 | MARK1 | 0.32480716 |
| 98 | BTK | 0.31890820 |
| 99 | PRKACA | 0.31615384 |
| 100 | TNK2 | 0.30469486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.82113743 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.11173896 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.10590904 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69873773 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.58257482 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46884931 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02405414 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95969160 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.91939291 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90624833 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.88852506 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 1.88748907 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.83144079 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.81547222 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71546546 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.70393828 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66755243 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64475556 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63695148 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.63483617 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63432747 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.61919498 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61169132 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.60543354 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.52541496 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52394701 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48414894 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46783241 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46694484 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45495811 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43956278 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.43750556 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41319751 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40364898 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33136441 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32792543 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.30315878 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.26863601 |
| 39 | DNA replication_Homo sapiens_hsa03030 | 1.24355029 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23987514 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.20019893 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19373043 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15638004 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12242394 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11149674 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09820089 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.09492106 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08855596 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07356565 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97843924 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97786674 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97597426 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97581885 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97388353 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97217965 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93639478 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92924231 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84984289 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80007919 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79770390 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79266930 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77655422 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76621475 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75591468 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72931672 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72871867 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72602699 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70016765 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69756808 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68303297 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67432658 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65657860 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65388274 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64479239 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64236322 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64163856 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63826047 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60107586 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58713037 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54945944 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54772099 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52162225 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48151989 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47169481 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46489596 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46295216 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44473376 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44282764 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43788863 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42550580 |
| 91 | Ribosome_Homo sapiens_hsa03010 | 0.37368567 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37199531 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.36712049 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36624114 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36255307 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35504971 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33938138 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33790862 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33341736 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33328056 |

